tarka 240 mg/4 mg
abbvie deutschland gmbh&co. kg - germania - combinatii (verapamilum+trandolaprilum) - compr. cu elib. prel. - 240mg/4mg - combinatii de inhibitori a.c.e. inhibitori ai e.c.a. si blocante ale canalelor de calciu
tarka 180 mg/2 mg
abbvie deutschland gmbh & co. kg - germania - combinatii (verapamilum+trandolaprilum) - compr. cu elib. prel. - 180mg/2mg - combinatii de inhibitori ai e.c.a. inhibitori ai e.c.a. si blocante ale canalelor de calciu
isoptin rr 240 mg
abbvie deutschland gmbh & co. kg - germania - verapamilum - compr. elib. prel. - 240mg - bloc. selective canale calciu cu ef. cardiace directe fenilalchilamine
tepkinly
abbvie deutschland gmbh & co. kg - epcoritamab - lymphoma, large b-cell, diffuse - agenți antineoplazici - tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) after two or more lines of systemic therapy.
aluvia comprimate filmate 200 mg + 50 mg
abbvie biopharmaceuticals gmbh - lopinavirum + ritonavirum - comprimate filmate - 200 mg + 50 mg
vylvio 12,5 mg/75 mg/50 mg comprimate filmate
abbvie biopharmaceuticals gmbh - ombitasvir + paritaprevir + ritonavir - comprimate filmate - 12,5 mg/75 mg/50 mg
vyrelakir 250 mg comprimate filmate
abbvie biopharmaceuticals gmbh - dasabuvirum - comprimate filmate - 250 mg
ganfort
abbvie deutschland gmbh & co. kg - bimatoprost, timolol - glaucoma, open-angle; ocular hypertension - oftalmologice - reducerea presiunii intraoculare (pio) la pacienții cu glaucom cu unghi deschis sau hipertensiune oculară, care nu răspund insuficient la beta-blocantele topice sau la analogii de prostaglandină.
skyrizi
abbvie deutschland gmbh & co. kg - risankizumab - psoriasis; arthritis, psoriatic - imunosupresoare - plaque psoriasisskyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisskyrizi, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). crohn's diseaseskyrizi is indicated for the treatment of adult patients with moderately to severely active crohn's disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy.
constella
abbvie deutschland gmbh & co. kg - linaclotide - sindromul colonului iritabil - medicamente pentru constipație - constella este indicat pentru tratamentul simptomatic al sindromului intestinal iritabil moderat până la sever cu constipatie (ibs-c) la adulți.